10-K: Bullfrog AI Holdings Details Common Stock and Warrant Specifications in 10-K Filing

Bullfrog AI Holdings provides a detailed description of its common stock and warrants in its latest 10-K filing, outlining key features and potential anti-takeover effects.

Summary

• Bullfrog AI Holdings, Inc. has filed its 10-K report detailing the characteristics of its Common Stock and Tradeable Warrants.
• The company is authorized to issue up to 100,000,000 shares of Common Stock with a par value of $0.00001 per share, each share entitling the holder to one vote.
• Holders of Common Stock are entitled to receive dividends if declared by the board and share ratably in net assets upon liquidation.
• The company is also authorized to issue up to 10,000,000 shares of blank-check preferred stock, which could affect the voting rights and control of the company.
• Each Tradeable Warrant is exercisable into one share of common stock at an exercise price of $7.80, expiring five years after the date of issuance.
• The Tradeable Warrants are listed on the Nasdaq Capital Market under the symbol BFRGW.
• Certain provisions of Nevada law, the Amended Articles of Incorporation, and the Bylaws may have an anti-takeover effect, potentially limiting the price investors might be willing to pay for shares.
• As of June 30, 2024, the aggregate market value of the common stock held by non-affiliates was approximately $9.0 million.
• As of March 11, 2025, there were 9,415,525 shares of the company's common stock outstanding.

Sentiment

Score: 5

Explanation: The document is primarily descriptive and factual, lacking strong positive or negative sentiment. It outlines the company's capital structure and potential risks, which is standard for a 10-K filing.

Positives

• Holders of common stock are entitled to receive dividends, if any, as may be declared by the board of directors.
• The company's warrants are listed on the Nasdaq Capital Market, providing liquidity for warrant holders.

Negatives

• Issuance of preferred stock could delay or prevent a change in control of the company and may adversely affect the rights of common stockholders.
• Certain provisions of Nevada law and the company's governing documents may have an anti-takeover effect, potentially limiting the price investors might be willing to pay for shares.

Risks

• The existence of authorized but unissued shares of preferred stock may enable the Board of Directors to render more difficult or discourage an attempt to obtain control of the Corporation.
• Anti-takeover measures could limit the price that investors might be willing to pay in the future for shares of our common stock.

Future Outlook

The document does not provide a specific future outlook beyond the general business strategy and potential revenue sources.

Industry Context

This announcement is typical for publicly traded companies, providing transparency to investors regarding the company's capital structure and potential risks. The anti-takeover provisions are common and aim to protect the company's long-term strategy.

Comparison to Industry Standards

• The authorized share capital and par value are typical for companies of this size and stage.
• The warrant structure is similar to those used by other companies raising capital through public offerings.
• Anti-takeover provisions are common among publicly traded companies to protect against hostile takeovers; examples include poison pills and staggered boards, which are implemented by companies such as AbbVie and Amgen.

Stakeholder Impact

• Shareholders are provided with detailed information about the company's capital structure and potential risks.
• Potential acquirers are alerted to the existence of anti-takeover provisions.

Key Dates